SK122897A3 - Application of 8,9-dehydroestrone as an estrogen with neutral effect on the prolactin level - Google Patents
Application of 8,9-dehydroestrone as an estrogen with neutral effect on the prolactin level Download PDFInfo
- Publication number
- SK122897A3 SK122897A3 SK1228-97A SK122897A SK122897A3 SK 122897 A3 SK122897 A3 SK 122897A3 SK 122897 A SK122897 A SK 122897A SK 122897 A3 SK122897 A3 SK 122897A3
- Authority
- SK
- Slovakia
- Prior art keywords
- dehydroestrone
- estrogen
- pharmaceutically acceptable
- prolactin
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72867696A | 1996-09-16 | 1996-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK122897A3 true SK122897A3 (en) | 1998-04-08 |
Family
ID=24927854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1228-97A SK122897A3 (en) | 1996-09-16 | 1997-09-11 | Application of 8,9-dehydroestrone as an estrogen with neutral effect on the prolactin level |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0829263A1 (ja) |
| JP (1) | JPH10101567A (ja) |
| KR (1) | KR19980024568A (ja) |
| AU (1) | AU3755397A (ja) |
| BR (1) | BR9704710A (ja) |
| CA (1) | CA2215655A1 (ja) |
| CZ (1) | CZ286397A3 (ja) |
| HU (1) | HUP9701542A3 (ja) |
| ID (1) | ID18256A (ja) |
| IL (1) | IL121755A0 (ja) |
| NZ (1) | NZ328739A (ja) |
| SG (1) | SG65684A1 (ja) |
| SK (1) | SK122897A3 (ja) |
| ZA (1) | ZA978305B (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3551459A (en) * | 1962-10-04 | 1970-12-29 | Herchel Smith | 13-methyl-8-isogonanes |
| US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
| US5395831A (en) * | 1994-04-08 | 1995-03-07 | American Home Products Corporation | Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone |
-
1997
- 1997-09-08 ID IDP973117A patent/ID18256A/id unknown
- 1997-09-11 SK SK1228-97A patent/SK122897A3/sk unknown
- 1997-09-11 EP EP97307047A patent/EP0829263A1/en not_active Withdrawn
- 1997-09-11 CZ CZ972863A patent/CZ286397A3/cs unknown
- 1997-09-12 CA CA002215655A patent/CA2215655A1/en not_active Abandoned
- 1997-09-12 IL IL12175597A patent/IL121755A0/xx unknown
- 1997-09-12 KR KR1019970046908A patent/KR19980024568A/ko not_active Application Discontinuation
- 1997-09-15 NZ NZ328739A patent/NZ328739A/xx unknown
- 1997-09-15 BR BR9704710A patent/BR9704710A/pt not_active Application Discontinuation
- 1997-09-15 ZA ZA978305A patent/ZA978305B/xx unknown
- 1997-09-15 HU HU9701542A patent/HUP9701542A3/hu unknown
- 1997-09-15 AU AU37553/97A patent/AU3755397A/en not_active Abandoned
- 1997-09-15 SG SG1997003412A patent/SG65684A1/en unknown
- 1997-09-16 JP JP9250316A patent/JPH10101567A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CZ286397A3 (cs) | 1998-03-18 |
| JPH10101567A (ja) | 1998-04-21 |
| HUP9701542A2 (hu) | 1998-06-29 |
| EP0829263A1 (en) | 1998-03-18 |
| BR9704710A (pt) | 1998-12-29 |
| KR19980024568A (ko) | 1998-07-06 |
| HUP9701542A3 (en) | 2000-01-28 |
| MX9706964A (es) | 1998-08-30 |
| SG65684A1 (en) | 1999-06-22 |
| CA2215655A1 (en) | 1998-03-16 |
| AU3755397A (en) | 1998-03-19 |
| IL121755A0 (en) | 1998-02-22 |
| HU9701542D0 (en) | 1997-10-28 |
| ZA978305B (en) | 1999-03-15 |
| NZ328739A (en) | 1999-08-30 |
| ID18256A (id) | 1998-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8450299B2 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| EP1446128B1 (en) | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy | |
| KR100385663B1 (ko) | 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물 | |
| AU2005294269B2 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| EP1260225A1 (en) | A pharmaceutical composition for use in hormone replacement therapy | |
| US7732430B2 (en) | Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception | |
| WO2004098517A2 (en) | Methods of hormonal treatment utilizing extended cycle contraceptive regimens | |
| KR20040066088A (ko) | 응급피임용 투약방법 및 약제학적 조성물 | |
| SK122897A3 (en) | Application of 8,9-dehydroestrone as an estrogen with neutral effect on the prolactin level | |
| DK164442B (da) | Svangerskabsforebyggende middel indeholdende en synergistisk blanding af aktive forbindelser | |
| MXPA97006964A (en) | Use of 8,9-dehydroestrone as a estrogen with neutral effects on the levels of prolact | |
| Segal | Contraceptives for the Twenty-First Century | |
| CA3234836A1 (en) | Contraceptive regimen including reduced level of estrogen | |
| US20230070977A1 (en) | Contraceptive regimen including reduced level of estrogen | |
| Paterson et al. | Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine. | |
| Horowski et al. | Lisuride—a new drug for treatment of hyperprolactinaemic disorders | |
| CN1178672A (zh) | 8,9－脱氢雌酮作为对催乳激素水平没有影响的雌激素的用途 | |
| JP2007197459A (ja) | 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬 | |
| AU2011203526A1 (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |